MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Alphatec Holdings Operating Expenses 2011-2026 | ATEC
Annual Operating Expenses Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 614 M | 560 M | 484 M | 380 M | 286 M | 161 M | 116 M | 83.2 M | 70 M | 87.5 M | 128 M | 143 M | 144 M | 134 M | 131 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 614 M | 70 M | 235 M |
Quarterly Operating Expenses Alphatec Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 M | 160 M | - | 136 M | 138 M | 141 M | - | 118 M | 114 M | 111 M | - | 94.5 M | 91.2 M | 90.4 M | - | 74.7 M | 76.8 M | 50.9 M | - | 42.1 M | 32 M | 38.8 M | - | 31.5 M | 29.3 M | 27.3 M | - | 23.7 M | 22.1 M | 15.6 M | - | 15.8 M | 16.5 M | 20.2 M | 21.7 M | 20.4 M | 21.5 M | 27.9 M | 29.1 M | 186 M | 23.7 M | 24.8 M | 34.7 M | 34.6 M | 34.3 M | 38 M | 91.3 M | 37.4 M | 35 M | 34.1 M | 36.1 M | 31.6 M | 33.9 M | 31.9 M | 41.4 M | 32.6 M | 33.2 M | 34.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 186 M | 15.6 M | 56.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.22 | 5.21 % | $ 3.47 M |  USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 10.45 | 0.29 % | $ 1.41 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 8.36 | -0.24 % | $ 600 M |  Israel |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.27 | 9.21 % | $ 904 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 71.2 | 2.02 % | $ 105 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.06 | 2.53 % | $ 151 M |  France |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 37.34 | -0.16 % | $ 1.16 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.68 | 4.61 % | $ 37 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.16 | 1.18 % | $ 302 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Establishment Labs Holdings
ESTA
|
185 M | $ 65.01 | 2.41 % | $ 1.93 B |  Costa-rica |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.45 | 0.16 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.65 | 1.64 % | $ 882 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 110.71 | 0.69 % | $ 193 B | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.74 | -0.71 % | $ 349 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.6 | 0.39 % | $ 153 M | Israel |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 269.48 | 3.15 % | $ 7.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.17 | -0.91 % | $ 1.32 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 32.75 | -0.27 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 176.12 | 3.94 % | $ 13.2 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.1 | 1.0 % | $ 701 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 33.74 | 2.99 % | $ 5.03 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
39.5 M | $ 3.74 | 1.91 % | $ 154 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.39 | -6.07 % | $ 40.1 M | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.33 | - | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
38.2 M | $ 102.8 | 1.09 % | $ 1.31 B | USA |